LVF with Cardiogenic Shock

Definition

Cardiogenic shock (CS) is a state of critical end-organ hypoperfusion due to primary cardiac failure. Clinically: SBP <90 mmHg (or MAP drop >30), signs of low output (cold/clammy, mottled), and evidence of pulmonary congestion (wet + cold = classic CS).

SCAI Shock Stages (A–E)

Stage	Description
A	At risk — no shock yet
B	Beginning — BP maintained, tachycardia, signs of congestion
C	Classic CS — hypoperfusion, hypotension, on vasopressors/inotropes
D	Deteriorating — failing despite initial support
E	Extremis — cardiac arrest / pre-arrest

Immediate Management

1. Stabilize Hemodynamics

Vasopressors: Norepinephrine is first-line (reduces mortality vs. dopamine)
Inotropes: Dobutamine if EF severely reduced; Milrinone (use cautiously in renal impairment)
Avoid aggressive diuresis if BP is low — differentiate wet-cold from wet-warm

2. Identify & Treat the Cause

Acute MI → urgent coronary angiography + PCI (within 90–120 min)
Acute decompensated HF → treat precipitant (arrhythmia, infection, medication non-compliance)
Echo: assess EF, wall motion, pericardial effusion, valve lesions

3. Mechanical Circulatory Support (MCS)

IABP (Intra-aortic balloon pump): reduces afterload, common first MCS
Impella (axial flow pump): highest evidence in cardiogenic shock
VA-ECMO: for refractory shock / cardiac arrest

4. Multidisciplinary Shock Team

Per Management of Heart Failure guidelines (p. 86): shock teams involving HF specialists, critical care, interventional cardiology, and cardiac surgery improve 30-day outcomes.

5. End Points of Resuscitation

MAP >65 mmHg
UO >0.5 mL/kg/hr
Lactate clearance >10% per hour
ScvO₂ >65%

AKI on Chronic Kidney Disease (Acute-on-CKD)

Distinction from Pure AKI

Per Evaluation and Management of CKD (p. 56), acute kidney disease (AKD) includes AKI occurring on a background of CKD. Both require:

Repeat GFR and kidney damage markers for staging
CKD is defined by ≥3 months of kidney damage/reduced GFR

Key Diagnostic Points

Baseline creatinine essential — compare to prior labs
Rise of ≥0.3 mg/dL within 48h OR ≥1.5× baseline within 7 days = AKI (KDIGO criteria)
Urine output <0.5 mL/kg/hr for >6h

Common Precipitants to Identify & Reverse

Category	Examples
Pre-renal	Volume depletion, cardiogenic shock, sepsis, NSAIDs
Intra-renal	Contrast nephropathy, aminoglycosides, obstruction
Post-renal	Urinary obstruction (BPH, stones)

Management

Identify & remove precipitant (top priority)
Volume status: cautious fluid resuscitation if pre-renal; avoid fluid overload in CKD
Hold nephrotoxins: NSAIDs, ACEi/ARB, metformin, contrast agents
Electrolytes: monitor K⁺, HCO₃⁻, phosphate closely — CKD reduces buffering capacity
Dose-adjust all medications for eGFR
Renal replacement therapy (RRT) indications: refractory hyperkalemia (K⁺ >6.5), severe acidosis (pH <7.1), refractory fluid overload, uremic symptoms

In the Context of LVF/Cardiogenic Shock

The combination of cardiogenic shock + AKI on CKD is particularly high-risk:

Renal perfusion falls with low cardiac output (cardiorenal syndrome Type 1)
Aggressive diuresis worsens AKI
Contrast for PCI carries added nephrotoxic risk — ensure adequate hydration, minimize contrast, consider iso-osmolar contrast
Inotrope/vasopressor selection must account for reduced renal clearance
Early nephrology + cardiology co-management is essential

Summary: In LVF with cardiogenic shock + AKI on CKD, priorities are: stabilize hemodynamics (vasopressors, MCS if needed), treat the underlying cardiac cause urgently, protect renal perfusion by avoiding pre-renal insults, hold nephrotoxins, and monitor for indications for RRT. Multidisciplinary team-based care is strongly recommended.

This is a shared conversation. Sign in to Orris to start your own chat.